When comparing the lineage subtypes of different AML-associated mutations, however, there is a clear enrichment of M1 and M2 AML associated with C/EBPα mutations [37], which are rather granulocytic or not yet committed blasts, although it is not clear if any K313 mutations were included in this study. This evidence concerns the gene CEBPA and acute myeloid leukemia.